Dr Tony Rukinski’s article about Cass does seem to ring true about the inherent weakness of Cass in accepting the category of’trans child’ hence giving credence to trans activists and setting up the groundwork for the puberty blocker trial which opens the door to their continuation.
The very drugs that ministers were finally persuaded must be banned ‘banned’ for use in gender clinics will now be given to vulnerable children inside government funded trials, complete with the blessing of senior medics and ethicists.
Worse still is that we have known this particular trial was going to happen for over six months while those doctors who’ve condemned it have been ignored.
For this is exactly what the Cass Review recommended and it is exactly why some of us could not join the chorus of conservatives and Christians hailing Cass as a decisive victory.
As TCW reported last April there was a ‘get-out clause’ included in Cass’s final report. It recommended that puberty-suppressing hormones should be prescribed only in the context of a clinical trial or under the guidance of the national multi-disciplinary team .The NHS in England and Scotland immediately took advantage of this.
Cass did say devastating things about the evidence base behind puberty blockers and cross sex hormones.
It found the research to be weak, biased and often incapable of showing whether these drugs actually improve mental health or reduce suicide risk.
For anyone who had watched Tavistock’s reckless approach for years, that official admission was welcome.
But instead of concluding that medical transition for children should be stopped as inherently unsafe, Cass accepted the category of the ‘trans child’ and recommended a ‘rigorous research programme’ to work out how best to treat them.
Cass to blame for puberty blocker trial